Deregulated microRNAs and Adiponectin in Postmenopausal Women with Breast Cancer

被引:14
作者
Isabel Pena-Cano, Maria [1 ]
Saucedo, Renata [2 ]
Morales-Avila, Enrique [1 ]
Valencia, Jorge [2 ]
Zavala-Moha, Jose A. [3 ]
Lopez, Adriana [4 ]
机构
[1] Univ Autonoma Estado Mexico, Fac Chem, Toluca, Mexico
[2] Inst Mexicano Seguro Social, Endocrine Res Unit, Natl Med Ctr, Cuauhtemoc 330, Mexico City 06720, DF, Mexico
[3] Reg Hosp 251, Inst Mexicano Seguro Social, Oncol Dept, Mexico City, DF, Mexico
[4] Reg Hosp 251, Inst Mexicano Seguro Social, Pathol Dept, Mexico City, DF, Mexico
关键词
Breast cancer; Menopause; Obesity; MicroRNA; Adiponectin; Leptin; Insulin-like growth factors; MIR-17-92; CLUSTER; OBESITY; OVERWEIGHT; EXPRESSION; LEPTIN; SERUM; METABOLISM; MECHANISMS; MORTALITY; DIAGNOSIS;
D O I
10.1159/000496340
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Obesity is a risk factor for breast cancer (BC). Some mechanisms through which obesity can lead to cancer development are insulin-like growth factors (IGFs), adipokines, and microRNAs (miRs). The objective of the study was to determine whether miR-17-5p, miR-195-5p, and miR-2213p expressions were deregulated in serum samples of obese and nonobese postmenopausal women with BC. In addition, insulin, adiponectin, leptin and IGFs were analyzed. Methods: Fifty postmenopausal women with newly diagnosed BC and 50 postmenopausal healthy women were evaluated. Differences in miRs between BC and healthy cases and between obese and lean participants were analyzed. Receiver operating characteristic curves for miRs for discriminating patients with or without BC were established, and relationships between the miRs, adipokines, and breast tumor characteristics were also investigated. Results: miR-17-5p and miR-195-5p were higher in patients with BC in comparison to the controls, while miR-221-3p and adiponectin were significantly lower. Increased levels of miR-195-5p allowed the differentiation of BC from controls with a sensitivity of 83.3 and a specificity of 78.3%, and were associated with lobular and poorly differentiated cancer. There was no difference in miRs levels between obese and lean groups. Conclusions: Circulating miRs and adiponectin were deregulated in postmenopausal women with BC. (C) 2019 S. Karger AG, Basel
引用
收藏
页码:369 / 377
页数:9
相关论文
共 50 条
  • [31] Combination of Endogenous Estradiol and Adipokine Leptin in Breast Cancer Risk and Prognosis Assessment in Postmenopausal Chinese Women
    Luo, Yang
    Li, Han-Bing
    Zhang, Yue
    Wu, Yu-Xin
    Shen, Di
    Che, Yi-Qun
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [32] Metabolic syndrome and the risk of breast cancer in postmenopausal women
    Rosato, V.
    Bosetti, C.
    Talamini, R.
    Levi, F.
    Montella, M.
    Giacosa, A.
    Negri, E.
    La Vecchia, C.
    ANNALS OF ONCOLOGY, 2011, 22 (12) : 2687 - 2692
  • [33] Adipocytokine imbalance and breast cancer in obese women
    Al Qteishat, Ahmed
    Aringazina, Raisa
    Ermakov, Dmitriy
    Demianenko, Elena
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 2) : S827 - S834
  • [34] Adipocytokine imbalance and breast cancer in obese women
    Al Qteishat, Ahmed
    Aringazina, Raisa
    Ermakov, Dmitriy
    Demianenko, Elena
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 : S827 - S834
  • [35] Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative
    Pan, Kathy
    Chlebowski, Rowan T.
    Mortimer, Joanne E.
    Gunther, Marc J.
    Rohan, Thomas
    Vitolins, Mara Z.
    Adams-Campbell, Lucile L.
    Ho, Gloria Y. F.
    Cheng, Ting-Yuan David
    Nelson, Rebecca A.
    CANCER, 2020, 126 (16) : 3638 - 3647
  • [36] Relationships between Follicle-Stimulating Hormone and Adiponectin in Postmenopausal Women
    Huang, Wan-Yu
    Chen, Dar-Ren
    Kor, Chew-Teng
    Chen, Ting-Yu
    Lin, Po-Te
    Tseng, Joseph Ta Chien
    Wu, Hung-Ming
    METABOLITES, 2020, 10 (10) : 1 - 10
  • [37] Adiponectin: A Predictor for Breast Cancer Survival?
    Guven, Hikmet Erhan
    Dogan, Lutfi
    Gulcelik, Mehmet Ali
    Gulcelik, Nese Ersoz
    EUROPEAN JOURNAL OF BREAST HEALTH, 2019, 15 (01) : 13 - 17
  • [38] The role of adiponectin and leptin in the treatment of ovarian cancer patients
    Slomian, Grzegorz
    Nowak, Damian
    Buczkowska, Marta
    Glogowska-Gruszka, Anna
    Slomian, Szymon Piotr
    Roczniak, Wojciech
    Janyga, Szymon
    Nowak, Przemyslaw
    ENDOKRYNOLOGIA POLSKA, 2019, 70 (01) : 57 - 63
  • [39] SERUM LEPTIN LEVEL IN BREAST CANCER
    Koprivcic, Ivan
    Marjanovic, Ksenija
    Matic, Anita
    Levak, Maja Tolusic
    Lovric, Ivan
    Pauzar, Biljana
    Eric, Ivan
    Wertheimer, Vjekoslav
    ACTA CLINICA CROATICA, 2022, 61 (01) : 79 - 85
  • [40] Prediagnostic Leptin, Adiponectin, C-Reactive Protein, and the Risk of Postmenopausal Breast Cancer
    Ollberding, Nicholas J.
    Kim, Yeonju
    Shvetsov, Yurii B.
    Wilkens, Lynne R.
    Franke, Adrian A.
    Cooney, Robert V.
    Maskarinec, Gertraud
    Hernandez, Brenda Y.
    Henderson, Brian E.
    Le Marchand, Loic
    Kolonel, Laurence N.
    Goodman, Marc T.
    CANCER PREVENTION RESEARCH, 2013, 6 (03) : 188 - 195